DFIs dig deep on ATOME’s green hydrogen fertiliser
Development banks have lined up behind ATOME’s Villeta green hydrogen fertiliser plant in Paraguay. Global supply chain disruptions have given the deal momentum, but DFI...
Development banks have lined up behind ATOME’s Villeta green hydrogen fertiliser plant in Paraguay. Global supply chain disruptions have given the deal momentum, but DFI...
Panama’s Metro Line 3 and Ruta del Este financings rely on strikingly different risk and revenue models. But together, they suggest that after a subdued spell, one of...
The liberalisation of Brazil’s water sector in 2020 has delivered on its promise of multi-sourced private investment. Will 2026 keep up the momentum?
Today’s Exile is Jorge Barrigh, Regional Director at Heifer Impact Capital. Jorge’s career has been defined by construction - whether that’s building engineering...
Given the urgency of energy transition related projects, DFI direct lending to project and export finance deals has risen significantly in recent years – but it is still...
Brazil's new infrastructure law has been broadly welcomed by the project finance market. In addition to providing stimulus for a wider infrastructure investor base, the...
The Africa Carbon Markets Initiative (ACMI) has secured $650 million of commitments for future carbon credits at the inaugural Africa Climate Summit. And given Africa’s...
There are confusing signals about what the role of BNDES will be under the new Lula administration. Will the bank continue to stimulate more private sector funding for...
There was a time when the IFC was all about infrastructure – especially in Latin America. Physical construction works that boosted GDP in the short-term and upgraded...
The Sao Paulo Linha 6/Laranja scheme is a pathfinder deal that exhibits BNDES’ new mantra on infrastructure investment, turns typical financing under a DFI umbrella on...
The EU is currently considering a financial framework for European multilateral and bilateral development banks – under the EFAD umbrella. But, as Paul Mudde, consultant...
Biovac’s EU-backed quasi-equity package and Brazil’s planned $1.2 billion vaccine PPP suggest that life-sciences are increasingly viewed as social infrastructure. But even vaccine sovereignty is hard to bank without public risk-sharing, demand visibility and unusually credible developers.